0
Comment(s)
*
* The moderation of comments is automated and not cleared manually by indianexpress.com.
By: Reuters |
February 3, 2021 10:08:22 pm
Serum Institute of India enters into a deal with WHO-led Covax Vaccine Scheme to supply 1.1 bn doses of AstraZeneca and Novavax. India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children’s Fund said on Wednesday.
UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries. They would be produced by Serum under a technology transfer agreement, she said in a briefing.
The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.